Clonal anergy is maintained independently of T cell proliferation

J Immunol. 2002 Dec 1;169(11):6178-86. doi: 10.4049/jimmunol.169.11.6178.

Abstract

Ag encounter in the absence of proliferation results in the establishment of T cell unresponsiveness, also known as T cell clonal anergy. Anergic T cells fail to proliferate upon restimulation because of the inability to produce IL-2 and to properly regulate the G(1) cell cycle checkpoint. Because optimal TCR and CD28 engagement can elicit IL-2-independent cell cycle progression, we investigated whether CD3/CD28-mediated activation of anergic T cells could overcome G(1) cell cycle block, drive T cell proliferation, and thus reverse clonal anergy. We show here that although antigenic stimulation fails to elicit G(1)-to-S transition, anti-CD3/CD28 mAbs allow proper cell cycle progression and proliferation of anergic T cells. However, CD3/CD28-mediated cell division does not restore Ag responsiveness. Our data instead indicate that reversal of clonal anergy specifically requires an IL-2-dependent, rapamycin-sensitive signal, which is delivered independently of cell proliferation. Thus, by tracing proliferation and Ag responsiveness of individual cells, we show that whereas both TCR/CD28 and IL-2-generated signals can drive T cell proliferation, only IL-2/IL-2R interaction regulates Ag responsiveness, indicating that proliferation and clonal anergy can be independently regulated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Antigens / administration & dosage
  • CD28 Antigens / metabolism
  • CD3 Complex / metabolism
  • Cell Division
  • Clonal Anergy*
  • Clone Cells
  • G1 Phase
  • Interleukin-2 / biosynthesis
  • Interleukin-2 / deficiency
  • Interleukin-2 / genetics
  • Interleukin-2 / pharmacology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Ovalbumin / immunology
  • Recombinant Proteins / pharmacology
  • Signal Transduction
  • Sirolimus / pharmacology
  • T-Lymphocytes / cytology*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*

Substances

  • Antibodies, Monoclonal
  • Antigens
  • CD28 Antigens
  • CD3 Complex
  • Interleukin-2
  • Recombinant Proteins
  • Ovalbumin
  • Sirolimus